0000318306-17-000001.txt : 20171218 0000318306-17-000001.hdr.sgml : 20171218 20171218161628 ACCESSION NUMBER: 0000318306-17-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171214 FILED AS OF DATE: 20171218 DATE AS OF CHANGE: 20171218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rouhandeh Steven H CENTRAL INDEX KEY: 0001294343 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15771 FILM NUMBER: 171261570 MAIL ADDRESS: STREET 1: C/O SCO CAPITAL PARTNERS LLC STREET 2: 1285 AVENUE OF THE AMERICAS 85TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC. CENTRAL INDEX KEY: 0000318306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830221517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3333 LEE PARKWAY STREET 2: SUITE 600 CITY: DALLAS STATE: TX ZIP: 75219 BUSINESS PHONE: 2149055100 MAIL ADDRESS: STREET 1: 3333 LEE PARKWAY STREET 2: SUITE 600 CITY: DALLAS STATE: TX ZIP: 75219 FORMER COMPANY: FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC DATE OF NAME CHANGE: 20140922 FORMER COMPANY: FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960209 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-12-14 0 0000318306 ABEONA THERAPEUTICS INC. ABEO 0001294343 Rouhandeh Steven H 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 1 1 1 0 Executive Chairman Srock option (right to buy) 16 2017-12-14 4 A 0 30000 0 A 2018-12-14 2027-12-14 Common stock 30000 30000 D Stock option (right to buy) 16 2017-12-14 4 A 0 90000 0 A 2019-01-14 2027-12-14 Common stock 90000 90000 D 100% accelerated vesting on change of control. After twelve months from the Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date. /s/ Steven H. Rouhandeh 2017-12-18